» Articles » PMID: 20145164

Studies of TMPRSS2-ERG Gene Fusions in Diagnostic Trans-rectal Prostate Biopsies

Overview
Journal Clin Cancer Res
Specialty Oncology
Date 2010 Feb 11
PMID 20145164
Citations 8
Authors
Affiliations
Soon will be listed here.
Citing Articles

Genomic rearrangements in prostate cancer.

Barbieri C, Rubin M Curr Opin Urol. 2014; 25(1):71-6.

PMID: 25393273 PMC: 4269103. DOI: 10.1097/MOU.0000000000000129.


Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospects.

Ferraldeschi R, Welti J, Luo J, Attard G, de Bono J Oncogene. 2014; 34(14):1745-57.

PMID: 24837363 PMC: 4333106. DOI: 10.1038/onc.2014.115.


ERG expression is associated with increased risk of biochemical relapse following radical prostatectomy in early onset prostate cancer.

Huang K, Dolph M, Donnelly B, Bismar T Clin Transl Oncol. 2014; 16(11):973-9.

PMID: 24796295 DOI: 10.1007/s12094-014-1182-x.


ERG Protein Expression Is of Limited Prognostic Value in Men with Localized Prostate Cancer.

Teng L, Wang C, Dolph M, Donnelly B, Bismar T ISRN Urol. 2013; 2013:786545.

PMID: 24027643 PMC: 3762160. DOI: 10.1155/2013/786545.


The mutational landscape of prostate cancer.

Barbieri C, Bangma C, Bjartell A, Catto J, Culig Z, Gronberg H Eur Urol. 2013; 64(4):567-76.

PMID: 23759327 PMC: 4342117. DOI: 10.1016/j.eururo.2013.05.029.


References
1.
Mosquera J, Mehra R, Regan M, Perner S, Genega E, Bueti G . Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States. Clin Cancer Res. 2009; 15(14):4706-11. PMC: 3717524. DOI: 10.1158/1078-0432.CCR-08-2927. View

2.
Guo C, Zuo G, Cao D, Troncoso P, Czerniak B . Prostate cancer of transition zone origin lacks TMPRSS2-ERG gene fusion. Mod Pathol. 2009; 22(7):866-71. DOI: 10.1038/modpathol.2009.57. View

3.
Clark J, Cooper C . ETS gene fusions in prostate cancer. Nat Rev Urol. 2009; 6(8):429-39. DOI: 10.1038/nrurol.2009.127. View

4.
Attard G, Swennenhuis J, Olmos D, Reid A, Vickers E, AHern R . Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer. Cancer Res. 2009; 69(7):2912-8. DOI: 10.1158/0008-5472.CAN-08-3667. View

5.
Attard G, Clark J, Ambroisine L, Fisher G, Kovacs G, Flohr P . Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer. Oncogene. 2007; 27(3):253-63. PMC: 2646890. DOI: 10.1038/sj.onc.1210640. View